SLG
CMD

Stanley-Laman Group’s Cantel Medical Corporation CMD Stock Holding History

Stanley-Laman Group’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-11,413
Closed -$809K – 342
2019
Q4 		$809K Buy
11,413
+1,621
+17% +$118K 0.19% 166
2019
Q3 		$732K Sell
9,792
-536
-5% -$45.4K 0.18% 174
2019
Q2 		$833K Sell
10,328
-557
-5% -$39.2K 0.2% 170
2019
Q1 		$728K Sell
10,885
-272
-2% -$20.6K 0.18% 191
2018
Q4 		$831K Buy
+11,157
New +$921K 0.23% 140

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Stanley-Laman Group's CMD Position: Q1 2020 in Review

Stanley-Laman Group sold out of Cantel Medical Corporation (CMD) in Q1 2020, closing a stake of 11,413 shares — an estimated $809K sold.

Stanley-Laman Group first reported a position in CMD in Q4 2018 and held it in 5 quarters. The position peaked at $833K in Q2 2019. 213 funds tracked by Wall St. Rank hold CMD as of Q1 2020.

  • Stanley-Laman Group reported no remaining Cantel Medical Corporation position as of Q1 2020 after selling out during the quarter.
  • Stanley-Laman Group sold 11,413 Cantel Medical Corporation shares in Q1 2020, an estimated $809K.
  • Stanley-Laman Group first reported a position in Cantel Medical Corporation in Q4 2018 and held it in 5 quarters.
  • Stanley-Laman Group's Cantel Medical Corporation position peaked at $833K in Q2 2019.
  • 213 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2020.

Based on Stanley-Laman Group's 13F filing for Q1 2020, filed 12 May 2020.